Your browser doesn't support javascript.
loading
Trends in rifampicin and isoniazid resistance in patients with presumptive TB.
Palani, N; Premkumar, M; Vaishnavee, V; Dinesh, V; Thiruvengadam, K; Lavanya, J; Sridhar, R; Frederick, A; Sivaramakrishnan, G; Mondal, R; Padmapriyadarsini, C; Shanmugam, S.
Afiliación
  • Palani N; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
  • Premkumar M; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
  • Vaishnavee V; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
  • Dinesh V; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
  • Thiruvengadam K; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
  • Lavanya J; District TB Office, Chennai, India.
  • Sridhar R; Goverment Hospital for Thoracic Medicine, Tambaram, India.
  • Frederick A; State TB Office, Tamil Nadu, India.
  • Sivaramakrishnan G; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
  • Mondal R; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India, ICMR-Bhopal Memorial Hospital & Research Centre, Bhopal, India.
  • Padmapriyadarsini C; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
  • Shanmugam S; Indian Council of Medical Research (ICMR)-National Institute for Research in Tuberculosis, Chennai, India.
Int J Tuberc Lung Dis ; 26(5): 446-453, 2022 05 01.
Article en En | MEDLINE | ID: mdl-35505474

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Francia